Table of Contents
ISRN Pediatrics
Volume 2012, Article ID 870549, 9 pages
http://dx.doi.org/10.5402/2012/870549
Research Article

Strain Echocardiography in Early Detection of Doxorubicin-Induced Left Ventricular Dysfunction in Children with Acute Lymphoblastic Leukemia

1Pediatric Cardiology Unit, Tanta University, Tanta 31111, Egypt
2Pediatric Hematology and Oncology Unit, Tanta University, Tanta 31111, Egypt
3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt

Received 14 September 2011; Accepted 19 October 2011

Academic Editors: M. S. Anderson and G. Siberry

Copyright © 2012 Mohammed Al-Biltagi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Curry, S. E. Parkes, J. E. Powell, and J. R. Mann, “Caring for survivors of childhood cancers: the size of the problem,” European Journal of Cancer, vol. 42, no. 4, pp. 501–508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Danesi and R. Zucchi, “Cardiac toxicity of antineoplastic anthracyclines,” Current Medicinal Chemistry—Anti-Cancer Agents, vol. 3, no. 2, pp. 151–171, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, “Anthracyclines: molecular advances and pharmacologie developments in antitumor activity and cardiotoxicity,” Pharmacological Reviews, vol. 56, no. 2, pp. 185–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. A. Wouters, L. C. M. Kremer, T. L. Miller, E. H. Herman, and S. E. Lipshultz, “Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies,” British Journal of Haematology, vol. 131, no. 5, pp. 561–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. O. J. Arola, A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen, and L. M. Voipio-Pulkki, “Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis,” Cancer Research, vol. 60, no. 7, pp. 1789–1792, 2000. View at Google Scholar · View at Scopus
  6. B. N. M. Zordoky, A. Anwar-Mohamed, M. E. Aboutabl, and A. O. S. El-Kadi, “Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats,” Toxicology and Applied Pharmacology, vol. 242, no. 1, pp. 38–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kruger and L. Wojnowski, “Cardiotoxicity of Anthracyclines—an Unsolved Problem,” Deutsches Arzteblatt, vol. 103, no. 37, pp. A2393–A2397, 2006. View at Google Scholar
  8. J. R. Carver, C. L. Shapiro, A. Ng et al., “American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3991–4008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Steinherz, P. G. Steinherz, C. T. C. Tan, G. Heller, and M. L. Murphy, “Cardiac toxicity 4 to 20 years after completing anthracycline therapy,” JAMA, vol. 266, no. 12, pp. 1672–1677, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D'Hooge, A. Heimdal, F. Jamal et al., “Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations,” European Journal of Echocardiography, vol. 1, no. 3, pp. 154–170, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Frigiola, A. N. Redington, S. Cullen, and M. Vogel, “Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of fallot,” Circulation, vol. 110, no. 11, pp. II153–II157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Li, G. Takemura, Y. Li et al., “Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy,” Circulation, vol. 113, no. 4, pp. 535–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Gottdiener, J. Bednarz, R. Devereux et al., “American Society of Echocardiography recommendations for use of echocardiography in clinical trials: a report from the american society of echocardiography's guidelines and standards committee and the task force on echocardiography in clinical trials,” Journal of the American Society of Echocardiography, vol. 17, no. 10, pp. 1086–1119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Al-Biltagi, M. Issa, H. A. Hagar, M. Abdel-Hafez, and N. A. Aziz, “Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis,” Acta Paediatrica, International Journal of Paediatrics, vol. 99, no. 10, pp. 1510–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. L. Goldman, “The κ statistic,” JAMA, vol. 11, pp. 2513–2514, 1992. View at Google Scholar
  16. K. Chatterjee, J. Zhang, N. Honbo, and J. S. Karliner, “Doxorubicin cardiomyopathy,” Cardiology, vol. 115, no. 2, pp. 155–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Q. Migrino, D. Aggarwal, E. Konorev, T. Brahmbhatt, M. Bright, and B. Kalyanaraman, “Detection of doxorubicin cardiomyopathy using 2-dimensional strain echocardiography,” Ultrasound in Medicine and Biology, vol. 34, no. 2, pp. 208–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sanderson, “Heart failure with a normal ejection fraction,” Heart, vol. 93, no. 2, pp. 155–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Iarussi, M. Galderisi, G. Ratti et al., “Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood,” Clinical Cardiology, vol. 24, no. 10, pp. 663–669, 2001. View at Google Scholar · View at Scopus
  20. L. Kapusta, J. M. Thijssen, J. Groot-Loonen, T. Antonius, J. Mulder, and O. Daniëls, “Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines,” Ultrasound in Medicine and Biology, vol. 26, no. 7, pp. 1099–1108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. E. Lipshultz, S. D. Colan, R. D. Gelber, A. R. Perez-Atayde, S. E. Sallan, and S. P. Sanders, “Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood,” The New England Journal of Medicine, vol. 324, no. 12, pp. 808–815, 1991. View at Google Scholar · View at Scopus
  22. H.-R. Tsai, O. Gjesdal, T. Wethal et al., “Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy,” American Journal of Cardiology, vol. 107, no. 3, pp. 472–477, 2011. View at Publisher · View at Google Scholar
  23. E. Piegari, G. Di Salvo, B. Castaldi et al., “Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model,” Ultrasound in Medicine and Biology, vol. 34, no. 3, pp. 370–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Urheim, T. Edvardsen, H. Torp, B. Angelsen, and O. A. Smiseth, “Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function,” Circulation, vol. 102, no. 10, pp. 1158–1164, 2000. View at Google Scholar · View at Scopus
  25. E. Yamada, M. Garcia, J. D. Thomas, and T. H. Marwick, “Myocardial Doppler velocity imaging—a quantitative technique for interpretation of Dobufamine echocardiography,” American Journal of Cardiology, vol. 82, no. 6, pp. 806–809, 1998. View at Google Scholar · View at Scopus